#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fibrosarcoma Endocrine ophthalmopathy Neuropathy peripheral Postprandial hypoglycaemia Antithrombin III deficiency Homocystinuria Alpha-1 antitrypsin deficiency Crigler-Najjar syndrome Extra-osseous Ewing's sarcoma metastatic Pleomorphic leiomyosarcoma Blastic plasmacytoid dendritic cell neoplasia Pneumonia Familial amyotrophic lateral sclerosis Thalassaemia alpha Ovarian cancer stage III More trials…

    Learn about Rare Diseases

    Pemphigus – Diagnostics Propionic acidaemia – Life with Disease Acquired haemophilia Langerhans’ cell histiocytosis – Diagnostics Richter’s syndrome – Life with Disease Pleomorphic leiomyosarcoma Noonan syndrome – Treatment Hereditary hypophosphataemic rickets Atypical haemolytic uraemic syndrome – Treatment Wolfram syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000070248 Vilanterol AZD1163 Corifollitropin Alfa Valbenazine Ditosylate Isoleucine Fenebrutinib AP31969 SULFATE Glipizide Maridebart Cafraglutide Vancomycin Hydrochloride Solifenacin Succinate Benzocaine Ascorbic Acid Bp Anhydrous Caffeine Progesterone Ph. Eur. Givinostat Cx-037231 Galunisertib Pyrazinamide More therapies…

    Learn about Your Condition

    Cervix carcinoma recurrent Nodular melanoma Bladder cancer stage II Pelvic venous thrombosis Retroperitoneal cancer Corneal graft failure Retroperitoneal fibrosis Erythema multiforme Major depression Glomerulonephritis Anal cancer stage II Rett syndrome Hypophosphatasia Anxiety Muscle strain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Kliiniliste Uuringute Keskus OÜ

Kliiniliste Uuringute Keskus OÜ

Sobra Tn 54/1, Tartu, 50106, Estonia

Want to learn more about this study or check if you can participate? Contact us.

  • Efficacy and safety of GB-0895 as adjunctive therapy in adults and adolescents with severe uncontrolled asthma (randomized, placebo‑controlled)

    Recruiting

    3 1
    Investigated Diseases:
    • Asthma
    Belgium Estonia France Ireland Italy Slovakia +1

  • Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Zasocitinib
    Belgium Bulgaria Croatia Czechia Estonia France +7

  • Study of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • MEASLES VIRUS EDMONSTON-SCHWARZ STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS
    • GSKVX000000025896
    • MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED)
    Belgium Bulgaria Denmark Estonia Greece Lithuania +2

  • Study on the Immune Response and Safety of a New Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Varicella
    Investigated Drugs:
    • VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED)
    • GSKVX000000025896
    • VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS
    Belgium Czechia Estonia Poland

  • Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

    Recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Zasocitinib
    • Apremilast
    Belgium Bulgaria Croatia Czechia Estonia Germany +6

  • Study of IM-250 capsules compared to placebo in patients with recurrent genital herpes

    Recruiting

    1 1
    Investigated Diseases:
    • Genital herpes simplex
    Investigated Drugs:
    • (S)-2-(2′,5′-DIFLUORO-[1,1′-BIPHENYL]-4-YL)-N-METHYL-N-(4-METHYL-5-(S-METHYLSULFONIMIDOYL)THIAZOL-2-YL)ACETAMIDE
    Bulgaria Estonia

  • Phase 2b Study of VXB-221 and VXB-213 Protein Vaccine for Prevention of Respiratory Syncytial Virus and Human Metapneumovirus Infections in Adults ≥60 Years

    Not yet recruiting

    2 1
    Czechia Estonia Finland Germany The Netherlands Poland +1

  • Study on the Effectiveness and Safety of IVX-A12 Vaccine for Preventing Respiratory Infections in Adults Aged 60 and Older

    Not yet recruiting

    3 1
    Investigated Drugs:
    • HUMAN METAPNEUMOVIRUS, VIRUS-LIKE PROTEIN
    Belgium Bulgaria Estonia Finland Germany Poland +2

  • Study on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Tocilizumab
    Bulgaria Czechia Estonia Hungary Lithuania Poland +1

  • Study on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis postmenopausal
    Investigated Drugs:
    • Calcium Lactate Gluconate
    • Calcium Carbonate
    • Denosumab
    Bulgaria Estonia Hungary Latvia Poland Slovakia
1 2 3
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!